Rectal Adenocarcinoma

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS withdrawal · 2016-10-12
Clinical Trial Update: Regorafenib in Reducing Recurrence in Patients With Non-metastatic Rectal Cancer Who Have Completed Curative-Intent Treatment [Phase 2]
The document notes that the Phase 2 trial of regorafenib to reduce recurrence in non-metastatic rectal cancer after curative treatment has b…